Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVAX Vaccine with Chemotherapy and PBMC in Advanced Prostate Cancer
NCT00122005Phase 2Unknown
- Start
- Jul 2005
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of GVAX pancreatic cancer vaccine in prostate cancer (PCa) (3 arms). Primary endpoints: Safety of combined CG1940 & CG8711, chemotherapy and hematopoietic reconstitution, Immune response of CG1940 & CG8711 vaccinated patients and 2 more. Status: unknown.
02
Drugs
GVAX pancreatic cancer vaccine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00122005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00122005.